RPE |
Retinal pigment epithelium |
RP |
Retinitis pigmentosa |
AMD |
Age-related macular degeneration |
DR |
Diabetic retinopathy |
RGC |
Retinal ganglion cell |
BRB |
Blood–retinal barrier |
ECM |
Extracellular matrix |
GA |
Geographic atrophy |
ROS |
Reactive oxygen species |
BM |
Bruch’s membrane |
MMPs |
Matrix metalloproteinases |
TIMPs |
Tissue inhibitors of metalloproteinases |
POAG |
Primary open-angle glaucoma |
GON |
Glaucomatous optic neuropathy |
IOP |
Intraocular pressure |
GWAS |
Genome-wide association study of glaucoma |
RHP |
Repetitive hypoxic preconditioning |
NO |
Nitric oxide |
ER |
Endoplasmic reticulum |
AAV |
Adeno-associated virus |
siRNA |
Small interference RNA |
CaMKII |
Calcium/calmodulin-dependent protein kinase II |
IRD |
Inherited retinal dystrophies |
DME |
Diabetic macular edema |
NPDR |
Nonproliferative diabetic retinopathy |
PDR |
Proliferative Diabetic retinopathy |
DME |
Diabetic macular edema |
DAG |
Diacylglycerol |
PKC |
Protein kinase C |
CML |
Nε-(carboxymethyl)lysine |
ALEs |
Advanced lipid oxidation end products |
MCP |
Monocyte chemoattractant protein-1 |
iNOS |
Inducible nitric oxide synthase |
COX-2 |
Cyclooxygenase-2 |
mtDNA |
Mitochondrial DNA |